We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > SpringWorks Therapeutics

News List

SpringWorks Therapeutics in pact with Janssen to assess Nirogacestat with Teclistamab in patients with relapsed or refractory multiple myeloma expresspharma
September 15, 2020
Third collaboration to evaluate nirogacestat in combination with BCMA therapies across modalities.
SpringWorks Therapeutics raises $125m for rare oncology programmes pharmaceutical-technology
April 03, 2019
US-based SpringWorks Therapeutics, which specialises on developing medicines and treatments for cancers and severe rare diseases, has raised $125m in a series B funding round led by Perceptive Advisors.
BeiGene and SpringWorks Therapeutics Enter into Global Clinical Collaboration to Evaluate Targeted Combination Therapy in Advanced Solid Tumors pharmafocusasia
September 10, 2018
BeiGene, Ltd., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, and SpringWorks Therapeutics, a clinical-stage rare disease and on
Pfizer spins out biotech firm with $103 million in funding biospectrumasia
September 27, 2017
Pfizer spins out biotech firm with $103 million in funding Over the past decade, many Pfizer drugs have found success outside the company.